14/10/2026
Malaysia’s sponsored clinical research industry has achieved another remarkable milestone, generating RM1 billion in Gross National Income (GNI) since 2023, bringing the industry's cumulative contribution to over RM2 billion!
What previously took more than a decade to achieve has now been accomplished in less than 4 years, reflecting the remarkable growth of Malaysia’s clinical research ecosystem.
At CRM, this achievement reflects the collective efforts of an ecosystem built on speed, quality, and reliability, strengthened through collaboration and a shared commitment to excellence.
Beyond the economic contribution, this progress is creating meaningful opportunities:
- More global drug development programmes are including Malaysia in their clinical trial footprint
- Malaysian investigators and study teams are gaining international recognition
- More patients are gaining access to innovative therapies through clinical research.
With Vision 2033 now ahead of schedule, this milestone reinforces Malaysia’s growing position as a trusted destination for sponsored clinical research.
Our heartfelt appreciation goes to all stakeholders, industry partners, investigators, and research professionals who have contributed to this success.
Together, we have raised the bar for Malaysia’s clinical research industry.
